Greece vs New Zealand: Pharmaceutical consumption
Pharmaceutical consumption over time
- Greece
- New Zealand
How they compare
Greece currently reports 352.1 Defined daily dose per 1 000 inhabitants per day against 351.1 Defined daily dose per 1 000 inhabitants per day in New Zealand, a difference of 1 Defined daily dose per 1 000 inhabitants per day.
The two have swapped places 3 times across 8 shared years of data; in 2018 it was New Zealand ahead.
Greece ranks 6th and New Zealand ranks 7th of 21 countries.
New Zealand has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Greece | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 261.15 Defined daily dose per 1 000 inhabitants per day | 348.5 Defined daily dose per 1 000 inhabitants per day | 87.35 Defined daily dose per 1 000 inhabitants per day | New Zealand |
| 2020s | 333.17 Defined daily dose per 1 000 inhabitants per day | 343.83 Defined daily dose per 1 000 inhabitants per day | 10.67 Defined daily dose per 1 000 inhabitants per day | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pharmaceutical consumption, Greece or New Zealand?
- Greece, at 352.1 Defined daily dose per 1 000 inhabitants per day against 351.1 Defined daily dose per 1 000 inhabitants per day in New Zealand as of 2025.
- What is the difference in pharmaceutical consumption between Greece and New Zealand?
- 1 Defined daily dose per 1 000 inhabitants per day, with Greece ahead.
- How many years of comparable data are there for Greece and New Zealand?
- 8 years are reported by both, from 2018 to 2025.
- How do Greece and New Zealand rank globally for pharmaceutical consumption?
- Greece ranks 6th and New Zealand ranks 7th of 21 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Pharmaceutical consumption. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Total pharmaceutical consumption according to the Anatomical Therapeutic Chemical (ATC) classification/Defined Daily Dose (DDD) system, created by the WHO Collaborating Centre for Drug Statistics Methodology. The unit of measurement is Defined Daily Dose (DDD), defined as the assumed average maintenance dose per day for a drug used on its main indication in adults. The Anatomical Therapeutic Chemical classification system divides drugs into different groups according to the organ system on which they act and/or therapeutical, pharmacological and chemical characteristics. The main principles for the classification of medicinal substances according to the ATC is presented in the publication “Guidelines for ATC classification and DDD assignment”, WHO Collaborating Centre for Drug Statistics Methodology, Oslo. The publication “ATC Index with DDDs” lists all assigned ATC codes and DDD values. Both these publications are updated annually. The ATC codes are based on the 2026 version of the ATC Index. All alterations implemented from January 2026 are available on the WHO Collaborating Centre for Drug Statistics Methodology website at https://www.whocc.no/lists_of__temporary_atc_ddds_and_alterations/. Data should reflect, where possible, the total consumption for each pharmaceutical drug category, i.e. including consumption in hospitals. Please refer to the Sources and Methods for detailed country-specific information.